Transdermal xenobiotics in newborn skin

Keyphrases

• Transdermal 100%
• Xenobiotics 100%
• Premature Infant 100%
• Newborn Skin 100%
• Topical Agents 40%
• Public Health Risk 20%
• Analgesia 20%
• Newborn Infant 20%
• Airway Hyperresponsiveness 20%
• Allergic Diseases 20%
• Iodine 20%
• Preterm Infants 20%
• Antimicrobial 20%
• Antisepsis 20%
• Medical Equipment 20%
• Maximum Tolerated Dose 20%
• Epidermis 20%
• Rash 20%
• Systemic Medications 20%
• Fully Developed 20%
• Hypothalamic-pituitary Axis 20%
• GloVe 20%
• Methylxanthines 20%
• Systemic Absorption 20%
• Skin Moisturization 20%
• Systemic Effects 20%
• Analgesic Agents 20%
• Povidone-iodine (PVP-I) 20%
• Natural Rubber Latex 20%
• Methemoglobinemia 20%
• Transdermal Administration 20%
• Common Agents 20%
• Steroid Cream 20%
• Topical Analgesics 20%
• Solvent Barriers 20%
• Eutectic Mixture of Local Anesthetics 20%
• Hospitalized Infants 20%
• Skin Barrier 20%
• Skin Exposure 20%

Nursing and Health Professions

• Prematurity 100%
• Topical Agent 40%
• Tincture of Iodine 40%
• Analgesia 20%
• Antiinfective Agent 20%
• Analgesic Agent 20%
• Cream 20%
• Rash 20%
• Medical Device 20%
• Lidocaine Plus Prilocaine 20%
• Methylxanthine 20%
• Antisepsis 20%
• Methemoglobinemia 20%
• Transdermal Drug Administration 20%
• Public Health 20%
• Steroid 20%
• Absorption 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Prematurity 100%
• Transdermal 100%
• Topical Agent 40%
• Iodine 40%
• Antiinfective Agent 20%
• Analgesic Agent 20%
• Rash 20%
• Methemoglobinemia 20%
• Methylxanthine 20%
• Lidocaine Plus Prilocaine 20%
• Topical Analgesics 20%
• Steroids 20%